133 related articles for article (PubMed ID: 11814472)
1. Determinants of glycated LDL levels in nondiabetic and diabetic hyperlipidaemic patients in Kuwait.
Akanji AO; Abdella N; Mojiminiyi OA
Clin Chim Acta; 2002 Mar; 317(1-2):171-6. PubMed ID: 11814472
[TBL] [Abstract][Full Text] [Related]
2. Beneficial changes in serum apo A-1 and its ratio to apo B and HDL in stable hyperlipidaemic subjects after Ramadan fasting in Kuwait.
Akanji AO; Mojiminiyi OA; Abdella N
Eur J Clin Nutr; 2000 Jun; 54(6):508-13. PubMed ID: 10878654
[TBL] [Abstract][Full Text] [Related]
3. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
Akanji AO; Abdullah A; Tahzeeb S
Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum biomarkers in nutritional disorders: glycated apolipoprotein B, fasting serum glucose, fructosamine, stable and labile glycated hemoglobin in diabetic and non-diabetic subjects.
De Michele G; Correale M; De Michele O; Guerra V; Mazzarelli R; Misciagna G
Immunopharmacol Immunotoxicol; 2008; 30(4):925-36. PubMed ID: 18720163
[TBL] [Abstract][Full Text] [Related]
6. Diabetic dyslipidaemia in Kuwait.
Akanji AO
Med Princ Pract; 2002; 11 Suppl 2():47-55. PubMed ID: 12444310
[TBL] [Abstract][Full Text] [Related]
7. Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition?
Moro E; Alessandrini P; Zambon C; Pianetti S; Pais M; Cazzolato G; Bon GB
Diabet Med; 1999 Aug; 16(8):663-9. PubMed ID: 10477211
[TBL] [Abstract][Full Text] [Related]
8. Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.
Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
Metab Syndr Relat Disord; 2009 Dec; 7(6):563-9. PubMed ID: 19642911
[TBL] [Abstract][Full Text] [Related]
9. Correlation between glycated lipoproteins and fructosamine level in serum.
Kobayashi K; Ogasahara N; Sakoguchi T; Taishi K; Makimura H; Matsuoka A
Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2149-51. PubMed ID: 1797439
[TBL] [Abstract][Full Text] [Related]
10. The relationships between insulin and plasminogen activator inhibitor 1 levels: assessment in groups of subjects with dyslipidaemia and hypertension.
Akanji AO; Al-Shayji I
Clin Chim Acta; 1998 Jun; 274(1):41-52. PubMed ID: 9681596
[TBL] [Abstract][Full Text] [Related]
11. Serum lipids and their relationship with other coronary risk factors in healthy subjects in a city clinic.
Khoo KL; Tan H; Liew YM
Med J Malaysia; 1997 Mar; 52(1):38-52. PubMed ID: 10968052
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E polymorphism and lipoprotein levels in a Gulf Arab population in Kuwait: a pilot study.
Al-Shammari S; Fatania H; Al-Radwan R; Akanji AO
Ann Saudi Med; 2004; 24(5):361-4. PubMed ID: 15573849
[TBL] [Abstract][Full Text] [Related]
13. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus.
Kissebah AH; Alfarsi S; Evans DJ; Adams PW
Diabetes; 1982 Mar; 31(3):217-25. PubMed ID: 7152129
[TBL] [Abstract][Full Text] [Related]
14. Screening for hyperlipidaemia in diabetes mellitus. Relationship to glycaemic control.
Paterson JR; Pettigrew AR; Dominiczak MH; Small M
Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():354-8. PubMed ID: 1892346
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages.
Zimmermann R; Panzenböck U; Wintersperger A; Levak-Frank S; Graier W; Glatter O; Fritz G; Kostner GM; Zechner R
Diabetes; 2001 Jul; 50(7):1643-53. PubMed ID: 11423487
[TBL] [Abstract][Full Text] [Related]
16. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes.
Chaturvedi N; Fuller JH; Taskinen MR;
Diabetes Care; 2001 Dec; 24(12):2071-7. PubMed ID: 11723085
[TBL] [Abstract][Full Text] [Related]
17. Diabetic dyslipidemia.
Kreisberg RA
Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of cultured smooth muscle cell proliferation and injury, utilizing glycated low density lipoproteins with slight oxidation, auto-oxidation, or extensive oxidation.
Taguchi S; Oinuma T; Yamada T
J Atheroscler Thromb; 2000; 7(3):132-7. PubMed ID: 11480453
[TBL] [Abstract][Full Text] [Related]
19. Glycated LDL concentrations in non-diabetic and diabetic subjects measured with monoclonal antibodies reactive with glycated apolipoprotein B epitopes.
Cohen MP; Lautenslager G; Shea E
Eur J Clin Chem Clin Biochem; 1993 Nov; 31(11):707-13. PubMed ID: 7508270
[TBL] [Abstract][Full Text] [Related]
20. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Navarro JF; Mora C; Muros M; García-Idoate G
Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
